Medical School, University of Saarland, Homburg, Germany.
Pediatr Neurol. 2012 Feb;46(2):63-9. doi: 10.1016/j.pediatrneurol.2011.11.021.
Evidence-based medicine in pediatric neurology is considered an important contributor to the best quality of care. We performed a literature review of all Cochrane reviews from 1996-2010 in pediatric neurology. Some reviews concluded that a certain intervention provided benefits, some concluded that certain interventions should not be performed, and some concluded that the current level of evidence was inconclusive. One hundred and twelve reviews were enrolled; only 17 exclusively involved children. In 33/112, a clear recommendation in favor of a certain intervention was given, 11/112 issued a conditionally positive recommendation, and 32/112 concluded that certain interventions should not be performed. Six concluded that no differences were evident between different therapeutic/treatment options. Thirty were inconclusive. The proportion of inconclusive reviews increased during three a priori defined time intervals. Common criticisms regarding quality of enrolled studies included heterogeneous study populations (49/112), a small number of participants (48/112), and a lack of comparability of studies (40/112). An ongoing need exists for high-quality research to reduce the proportion of inconclusive meta-analyses. Further randomized, controlled trials should involve only pediatric populations.
循证医学在儿科神经病学中被认为是提供最佳护理质量的重要因素。我们对 1996 年至 2010 年期间所有儿科神经病学 Cochrane 综述进行了文献回顾。一些综述得出结论认为某种干预措施提供了益处,一些结论认为某些干预措施不应进行,还有一些结论认为当前证据水平尚无定论。共纳入 112 项综述,仅 17 项完全涉及儿童。在 112 项综述中,33 项明确推荐某种干预措施,11 项有条件地推荐,32 项结论认为某些干预措施不应进行。6 项结论认为不同治疗/治疗选择之间没有明显差异。30 项结论不明确。在三个事先定义的时间间隔内,不明确的综述比例增加。对纳入研究质量的常见批评包括研究人群异质性(49/112)、参与者人数少(48/112)以及研究缺乏可比性(40/112)。需要进行高质量的研究来减少不明确的荟萃分析比例。进一步的随机对照试验应仅涉及儿科人群。